2026年7月30日 8:02 ET 发布 · 更新于 3 个月前 · 1 个来源
A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO
bloomberg
·
原始报道
Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector.
原文